Cytomegalovirus (CMV) continues to be one of the most important pathogens that
universally affect solid organ and allogeneic hematopoietic stem cell transplant recipients …

Orthotopic liver transplantation (OLT) is the standard of care for patients with
decompensated cirrhosis and for patients with hepatocellular carcinoma. More than 6000 …

The genomes of RNA and small DNA viruses of vertebrates display significant suppression
of CpG dinucleotide frequencies. Artificially increasing dinucleotide frequencies results in …

Human cytomegalovirus (HCMV) infection is common and affects between 40–100% of the
worldwide population. However, the majority of cases are asymptomatic and when severe …

The number of liver transplants (LT) performed worldwide continues to rise, and LT
recipients are living longer post‐transplant. This has led to an increasing number of LT …

Background. Control of cytomegalovirus (CMV) infection after solid organ transplantation
(SOT) requires a functional immune system. We assessed the association between …

The human cytomegalovirus major immediate early proteins IE1 and IE2 are critical drivers
of virus replication and are considered pivotal in determining the balance between …

Cytomegalovirus (CMV) infection is the most common viral infection in liver transplant
recipients, affecting post-transplant patients and graft survival. Recent advances in …

Background In transplant recipients, cytomegalovirus (CMV) infection increases morbidity
and mortality; furthermore, coinfection with other human herpesviruses like the Epstein‐Barr …

We systematically reviewed and meta-analyze the efficacy of universal prophylaxis (UP) and
preemptive (PE) strategies (using ganciclovir or valganciclovir) in preventing …